Moderna and Merck announced a successful clinical trial by August 21, 2026, for a personalized mRNA cancer vaccine paired with Merck's immunotherapy drug to treat melanoma. The breakthrough combines a customized vaccine designed to target specific cancer cells with immunotherapy.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
The treatment involves pairing Merck's immunotherapy drug with a customized mRNA vaccine that instructs the immune system to attack specific cancer cells.
this outlet adds: voila, personalizedmedicine, deal, really, years, family, left, home
l.smartnews.com/p-8kHswsSd/R... I wonder if Trumpers and GOP and supporters would take it? I sure hope not. Why don’t they just call themselves Christian Scientists, like the other whack jobs and avoid all medical care and let Jesus decide? CHICAGO, Aug 19 (Reuters) - Merck and Moderna's success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment t..
www.cnn.com/2026/08/21/h... Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors.